Jaguar Health reduces royalty debt by $1.016M via equity exchanges; Q1 results released

Jaguar Health, Inc.

Issued 60,000 shares to Iliad for $466,200 reduction in October 2020 royalty interest.
Exchanged all 99.3822 Series J shares for Series L perpetual preferred stock with Streeterville.
Issued 22 Series L shares to Iliad for $550,000 royalty reduction; Series L pays 0%/10%/15% preferred return.
Q1 2025 earnings press released (financial details not provided in filing).
Company will seek stockholder approval to exceed Nasdaq exchange cap for Series L conversions.

item 1.01 item 2.02 item 2.03 item 3.02 item 5.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.